| Molecular Formula | C27H24N2O5 |
| Molar Mass | 456.49 |
| Density | 1.278±0.06 g/cm3(Predicted) |
| Boling Point | 641.9±55.0 °C(Predicted) |
| Solubility | DMSO: 67.3 mg/mL |
| pKa | 4.21±0.10(Predicted) |
| Storage Condition | -20℃ |
| Physical and Chemical Properties | Bioactive AM095 is an antagonist of LPA1 receptor. The IC50 for human-derived recombinant LPA1 and mouse LPA1 is 0.98 μM and 0.73 μM respectively. |
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 2.191 ml | 10.953 ml | 21.906 ml |
| 5 mM | 0.438 ml | 2.191 ml | 4.381 ml |
| 10 mM | 0.219 ml | 1.095 ml | 2.191 ml |
| 5 mM | 0.044 ml | 0.219 ml | 0.438 ml |
| acidity coefficient (pKa) | 4.21±0.10(Predicted) |
| biological activity | AM095 is an antagonist of LPA1 receptor, and its IC50 for human recombinant LPA1 and mouse LPA1 is 0.98 μM and 0.73 μM respectively. |
| target | TargetValue LPA1 receptor () |
| Target | Value |